Teva Pharmaceutical Industries Ltd (TEVJF) Change in Receivables (2025 - 2026)
Teva Pharmaceutical Industries' (TEVJF) quarterly Change in Receivables came in at $91.0 million in Q2 2026, down 18.02% YoY from $111.0 million in Q2 2025, and up 216.67% on a QoQ basis from -$78.0 million in Q1 2026.
Teva Pharmaceutical Industries Ltd (TEVJF) Change in Receivables (2025 - 2026) Analysis & Trends
Teva Pharmaceutical Industries (TEVJF) has 2 years of Change in Receivables data on file, last reported at $91.0 million in Q2 2026.
- Quarterly Change in Receivables fell 18.02% year-over-year to $91.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$140.0 million (changed N/A YoY) and the FY2025 annual result came in at -$173.0 million, down 170.61% from the prior year.
- Change in Receivables grew to $91.0 million in Q2 2026, from -$78.0 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $111.0 million in Q2 2025 to a low of -$264.0 million in Q1 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 91.00 Mn |
| Jun 30, 2026 | 91.00 Mn |
| Mar 31, 2026 | -78.00 Mn |
| Mar 31, 2026 | -78.00 Mn |
| Jun 30, 2025 | 111.00 Mn |
| Jun 30, 2025 | 111.00 Mn |
| Mar 31, 2025 | -264.00 Mn |
| Mar 31, 2025 | -264.00 Mn |